Abstract

Diltiazem 5% in Lipoderm, Veterinary

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2008 - Compounding for Hospice and Cancer Patients

Page(s): 67

Download in electronic PDF format for $75
  • Diltiazem 5% in Lipoderm, Veterinary Page 1

Abstract

A formulation for preparing Diltiazem 5% in Lipoderm, Veterinary. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • diltiazem
  • feline hypertrophic cardiomyopathy
  • cats
  • topical preparations
  • lipoderm
  • veterinary

Related Categories

  • FORMULATIONS
  • VETERINARY
  • CARDIOLOGY
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2003
Pg. 106-113
Veterinary Transdermal Medications: A to Z
Author(s): Davidson Gigi S
Jan/Feb 2008
Pg. 67
Diltiazem 5% in Lipoderm, Veterinary
Author(s): Allen Loyd V Jr
May/Jun 2024
Pg. 244
Diltiazem 5% in Lipoderm, Veterinary
Author(s): Allen Loyd V Jr
Sep/Oct 2008
Pg. 392-397
Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases
Author(s): Mixon William, Helms Scott R
Nov/Dec 2020
Pg. 482-490
Stability of Compounded Diltiazem Hydrochloride in Cream, Ointment, and Gel Formulations for Topical Use
Author(s): Teimouri Arezou, Yeung Pollen, Agu Remigius U
Nov/Dec 2020
Pg. 501-508
Drug-release Assessment of Compounded Topical Nifedipine and Diltiazem in Commonly Used Bases for Wound Healing
Author(s): Teimouri Arezou, Yeung Pollen, Agu Remigius U
Sep/Oct 2019
Pg. 428-433
The Current Landscape of Veterinary Compounding in the Veterinary Setting
Author(s): Gochenauer Alexandria E, Rishniw Mark, Holmes Erin R, Forsythe Lauren R
Jul/Aug 2004
Pg. 269-274
Current Topical Treatments in Wound Healing - Part 1
Author(s): Helmke Christopher D
Nov/Dec 2018
Pg. 493
Diltiazem Hydrochloride 12 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
May/Jun 2012
Pg. 241
Diltiazem Hydrochloride 5-mg/mL Injection
Author(s): Allen Loyd V Jr
Sep/Oct 2019
Pg. 422-427
The Current Landscape of Veterinary Compounding in the Pharmacy Setting
Author(s): Gochenauer Alexandria E, Holmes Erin R, Barber Katie E, Forsythe Lauren R
Nov/Dec 2017
Pg. 446-452
Feline Transdermal Formulation Considerations
Author(s): Forsythe Lauren Eichstadt
Sep/Oct 2014
Pg. 366-369
To Compound or Not to Compound: A Veterinary Transdermal Discussion
Author(s): Eichstadt Lauren R, Davidson Gigi S
Jan/Feb 2016
Pg. 50
Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm
Author(s): Allen Loyd V Jr
Mar/Apr 2019
Pg. 149
Dexamethasone 2 mg/g Topical Paste, Veterinary
Author(s): Allen Loyd V Jr
Mar/Apr 2024
Pg. 133
Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm
Author(s): Allen Loyd V Jr
May/Jun 2017
Pg. 242-246
Absorption of Transdermal Fluoxetine Compounded in a Lipoderm Base Compared to Oral Fluoxetine in Client-owned Cats
Author(s): Eichstadt Lauren R, Corriveau Lorraine A, Moore George E, Knipp Gregory T, Cooper Bruce R, Gwin Wilson E
Mar/Apr 2001
Pg. 86-88
The Use of Psychoactive Agents in Veterinary Medicine
Author(s): Simpson Barbara S
Jan/Feb 2002
Pg. 43
Diltiazem HCl 2% Topical Gel
Author(s): Allen Loyd V Jr
Nov/Dec 2022
Pg. 468-472
Unlicensed Transdermal Medications in Feline Patients: Three Case Reports
Author(s): Urwin Craig, Jean Linda, Carvalho Maria, Robson-Laws Michael